abstract |
The present invention relates to the use of human small leucine zipper proteins in the process of adipocyte differentiation, and more particularly, sLZIP binds to PPARγ2 to induce complex formation of HDAC3 with PPARγ2, thereby acting as an inhibitory complement of PPARγ2, Can be used as markers for the development of new drugs for treatment and treatment of diabetes, obesity and the like. |